Literature DB >> 9579371

Delayed cellulitis associated with conservative therapy for breast cancer.

S R Miller1, T Mondry, J S Reed, A Findley, P A Johnstone.   

Abstract

BACKGROUND AND OBJECTIVES: Delayed breast cellulitis is an infrequently reported entity after conservation therapy for breast cancer. We describe our experience with this entity at Naval Medical Center, San Diego.
METHODS: Eight patients who presented with delayed cellulitis after wide local excision/axillary dissection and breast radiotherapy (RT) are presented. Their clinical characteristics and therapy are described and possible causative factors are analyzed.
RESULTS: The latency of breast cellulitis is variable after breast conservation therapy, although most cases in our experience and in the literature occur within a year post-RT. These infections are frequently refractory to a single course of antibiotics (n = 4 cases in our experience). Some patients suffer multiple episodes separated by months.
CONCLUSIONS: Breast cancer patients are at risk for delayed cellulitis after conservative surgery and RT. The mechanism of such events probably involves lymph stasis, however, therapy is no different from the more frequently occurring cases of cellulitis presenting perioperatively.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579371     DOI: 10.1002/(sici)1096-9098(199804)67:4<242::aid-jso6>3.0.co;2-8

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy.

Authors:  H Badakhshi; D Kaul; J Nadobny; B Wille; J Sehouli; V Budach
Journal:  Br J Radiol       Date:  2013-10-28       Impact factor: 3.039

2.  Delayed Breast Cellulitis following Surgery for Breast Cancer: A Literature Review.

Authors:  Georgios Exarchos; Linda Metaxa; Anastasia Constantinidou; Michalis Kontos
Journal:  Breast Care (Basel)       Date:  2018-12-01       Impact factor: 2.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.